简体
简体中文
繁體中文

Themes ETF Trust Themes China Generative Artificial Intelligence ETF DRGN

等待开盘 09-23 09:30:00 美东时间

36.91

+0.760

+2.10%

华盛通华盛通
立即下载
  • 最 高36.955
  • 今 开36.92
  • 成交量 4.81万股
  • 最 低 36.5769
  • 昨 收 36.15
  • 总市值 0
  • 52周最高 36.955
  • 市盈率 --
  • 换手率 Infinity.00%
  • 52周最低 25.72
  • 委 比 -73.68%
  • 总股本 --
  • 历史最高 36.955
  • 量 比 1.58
  • 振 幅 1.05%
  • 历史最低 25.72
  • 每 手 1
  • 风险率 3.30%

个股概要

财务分析

公司资料

相关新闻

分红派息

  • 分时图
  • 日k
  • 周k
  • 月k

相关新闻

更多
  • Draganfly Demonstrates the Commander 3XL and Flex FPV Capabilities at T-REX 24-2 Military Technology Exercise

    Draganfly Inc. successfully demonstrated its Commander 3XL and Flex FPV drones during the U.S. Department of Defense's T-REX 24-2 exercise at Camp Atterbury, Indiana. These drones showcased critical capabilities, including multi-domain operations, ultra-low-latency intelligence in GPS-denied environments, and real-time target acquisition. The exercise highlighted Draganfly's role as a leading developer of versatile and adaptable drone systems for...

    09-03 11:15

  • Draganfly Uniquely Positioned to Support Canada’s New $2 Billion Military Commitment to Ukraine with Advanced Drone and Tactical Capabilities

    Draganfly Inc., a leading drone solutions developer, announced its strategic role in supporting Canada's $2 billion military aid package for Ukraine, with a focus on drone, counter-drone, and electronic warfare capabilities. As the world’s oldest dual-use drone manufacturer, Draganfly is well-positioned to contribute advanced UAV, ISR, counter-drone technologies, and demining support to Ukraine. The company's expertise and experience in Ukraine s...

    08-26 11:15

  • Draganfly Announces Closing of US$25.0 Million Registered Direct Offering

    Draganfly Inc. completed a registered direct offering of 4,672,895 units at US$5.35 per unit, raising approximately US$25.0 million. Each unit includes one common share and one warrant exercisable at CA$7.3579, expiring in five years. Maxim Group LLC acted as the sole placement agent. Proceeds will be used for general corporate purposes, product development, and growth initiatives. The offering was conducted in the U.S. under SEC regulations, wit...

    07-21 20:19